Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin

Vitreomacular traction and vitreomacular traction with macular hole are conditions associated with visual disturbance and decreased visual acuity. Recent studies have demonstrated that ocriplasmin is effective and safe in specific patient groups with vitreomacular traction, and hence is recommended...

Descripción completa

Detalles Bibliográficos
Autores principales: DaCosta, Joanna, Younis, Saad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251743/
https://www.ncbi.nlm.nih.gov/pubmed/25473315
http://dx.doi.org/10.2147/DHPS.S75244
_version_ 1782347086992244736
author DaCosta, Joanna
Younis, Saad
author_facet DaCosta, Joanna
Younis, Saad
author_sort DaCosta, Joanna
collection PubMed
description Vitreomacular traction and vitreomacular traction with macular hole are conditions associated with visual disturbance and decreased visual acuity. Recent studies have demonstrated that ocriplasmin is effective and safe in specific patient groups with vitreomacular traction, and hence is recommended as a treatment option. We present here a case report of a patient treated with intravitreal ocriplasmin associated with severe loss of vision and delayed resolution of vitreomacular traction. This report highlights that it is important for patients to be made fully aware of the risks of intravitreal ocriplasmin and the prognosis for visual improvement.
format Online
Article
Text
id pubmed-4251743
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-42517432014-12-03 Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin DaCosta, Joanna Younis, Saad Drug Healthc Patient Saf Case Report Vitreomacular traction and vitreomacular traction with macular hole are conditions associated with visual disturbance and decreased visual acuity. Recent studies have demonstrated that ocriplasmin is effective and safe in specific patient groups with vitreomacular traction, and hence is recommended as a treatment option. We present here a case report of a patient treated with intravitreal ocriplasmin associated with severe loss of vision and delayed resolution of vitreomacular traction. This report highlights that it is important for patients to be made fully aware of the risks of intravitreal ocriplasmin and the prognosis for visual improvement. Dove Medical Press 2014-11-25 /pmc/articles/PMC4251743/ /pubmed/25473315 http://dx.doi.org/10.2147/DHPS.S75244 Text en © 2014 DaCosta and Younis. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Case Report
DaCosta, Joanna
Younis, Saad
Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin
title Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin
title_full Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin
title_fullStr Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin
title_full_unstemmed Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin
title_short Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin
title_sort transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251743/
https://www.ncbi.nlm.nih.gov/pubmed/25473315
http://dx.doi.org/10.2147/DHPS.S75244
work_keys_str_mv AT dacostajoanna transientvisuallossanddelayedresolutionofvitreomaculartractionafterintravitrealocriplasmin
AT younissaad transientvisuallossanddelayedresolutionofvitreomaculartractionafterintravitrealocriplasmin

Ejemplares similares